過活動膀胱治療の世界市場レポート 2024年

過活動膀胱治療の市場規模は近年着実に成長しています。2023年の30億1,000万米ドルから2024年には31億3,000万米ドルへと、CAGR3.8％で拡大する見込みです。過去一定期間に観察された成長は、薬物療法の進歩、患者の意識の向上、人口動態の変化、臨床ガイドラインの遵守、研究への多額の投資に起因しています。

膀胱がんの蔓延も、過活動膀胱治療市場成長の重要な促進要因です。膀胱がんは、膀胱内の異常な細胞増殖を特徴とし、しばしば過活動膀胱の症状を示します。こうした症状を治療することは、膀胱がん患者の生活の質を向上させるために極めて重要です。米国臨床腫瘍学会の2023年3月の推計によると、米国の成人約82,290人が膀胱がんと診断され、2023年には約16,710人が死亡すると予想されています。このことは、膀胱がんと過活動膀胱の有病率の相関関係を強調し、市場の成長に寄与しています。

2023年の過活動膀胱治療市場で最大の地域は北米です。アジア太平洋は、過活動膀胱治療市場レポートにおいて予測期間中に最も急成長する地域となる見込みです。過活動膀胱治療市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 過活動膀胱治療市場の特徴

第3章 過活動膀胱治療市場の動向と戦略

第4章 過活動膀胱治療市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の過活動膀胱治療市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 過活動膀胱治療市場セグメンテーション

• 世界の過活動膀胱治療市場、疾患タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 特発性膀胱過活動
• 神経因性膀胱過活動
• 世界の過活動膀胱治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗コリン薬
• ミラベグロン
• 神経刺激
• 膀胱内注入
• その他
• 世界の過活動膀胱治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• ドラッグストアおよび小売薬局
• オンラインプロバイダー

第7章 過活動膀胱治療市場の地域および国分析

• 世界の過活動膀胱治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の過活動膀胱治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の過活動膀胱治療市場

第9章 中国の過活動膀胱治療市場

第10章 インドの過活動膀胱治療市場

第11章 日本の過活動膀胱治療市場

第12章 オーストラリアの過活動膀胱治療市場

第13章 インドネシアの過活動膀胱治療市場

第14章 韓国の過活動膀胱治療市場

第15章 西欧の過活動膀胱治療市場

第16章 英国の過活動膀胱治療市場

第17章 ドイツの過活動膀胱治療市場

第18章 フランスの過活動膀胱治療市場

第19章 イタリアの過活動膀胱治療市場

第20章 スペインの過活動膀胱治療市場

第21章 東欧の過活動膀胱治療市場

第22章 ロシアの過活動膀胱治療市場

第23章 北米の過活動膀胱治療市場

第24章 米国の過活動膀胱治療市場

第25章 カナダの過活動膀胱治療市場

第26章 南米の過活動膀胱治療市場

第27章 ブラジルの過活動膀胱治療市場

第28章 中東の過活動膀胱治療市場

第29章 アフリカの過活動膀胱治療市場

第30章 過活動膀胱治療市場の競合情勢と企業プロファイル

• 過活動膀胱治療市場の競合情勢
• 過活動膀胱治療市場の企業プロファイル
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Laborie Medical Technologies Corporation
  • Endo International plc
  • Hisamitsu Pharmaceutical Co. Inc.

第31章 世界の過活動膀胱治療市場の競合ベンチマーキング

第32章 世界の過活動膀胱治療市場競争力ダッシュボード

第33章 過活動膀胱治療市場における主要な合併と買収

第34章 過活動膀胱治療市場の将来展望と可能性分析

第35章 付録

“Overactive Bladder Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on overactive bladder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for overactive bladder treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The overactive bladder treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Diseases Type: Idiopathic Bladder Overactivity; Neurogenic Bladder Overactivity
• 2) By Therapy: Anticholinergics; Mirabegron; Neurostimulation; Intravesical Instillation; Other Therapies
• 3) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
• Companies Mentioned: AbbVie Inc.; Astellas Pharma Inc.; Laborie Medical Technologies Corporation; Endo International plc; Hisamitsu Pharmaceutical Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Overactive bladder encompasses a range of symptoms that can impact a person's frequency of urination and the sense of urgency. Treatment involves modifying specific behaviors, incorporating pelvic floor muscle exercises, and other measures aimed at alleviating symptoms. The objective of treatment is to effectively address the symptoms of an overactive bladder and decrease instances of urgent incontinence.

The primary categories of diseases in the treatment of overactive bladder are idiopathic bladder overactivity and neurogenic bladder overactivity. Idiopathic bladder overactivity involves an involuntary contraction of the bladder muscle, leading to a sudden and urgent urge to urinate. This condition is managed through overactive bladder (OAB) treatment methods, including anticholinergics and beta-3 agonists. Various therapies such as anticholinergics, mirabegron, neurostimulation, intravesical instillation, and other approaches are employed to treat these diseases. These therapies are available through channels such as hospital pharmacies, drug stores, retail pharmacies, and online providers.

The overactive bladder treatment market research report is one of a series of new reports from The Business Research Company that provides overactive bladder treatment market statistics, including overactive bladder treatment industry global market size, regional shares, competitors with an overactive bladder treatment market share, detailed overactive bladder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the overactive bladder treatment industry. This overactive bladder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The overactive bladder treatment market size has grown steadily in recent years. It will grow from $3.01 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth observed during the historical period can be ascribed to advancements in medication, increased patient awareness, demographic changes, adherence to clinical guidelines, and substantial investments in research.

The overactive bladder treatment market size is expected to see steady growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The anticipated growth in the forecast period can be linked to factors such as an aging population, the development of advanced therapies, the implementation of personalized medicine, increased healthcare investments, and a focus on patient-centric care. Key trends expected during this period encompass non-pharmacological interventions, the adoption of digital health solutions, growing acceptance of alternative medicine, the incorporation of gender-specific approaches, and an emphasis on holistic care.

The overactive bladder treatment market is poised for growth, driven by the increasing elderly population. With the geriatric demographic, encompassing individuals aged 65 and older, being more susceptible to urinary tract infections due to factors such as diminished urine flow, overactive bladder, enlarged prostate, or kidney stones, there is a heightened demand for treatments targeting overactive bladder symptoms. As reported in July 2022 by ReliefWeb, the global population aged 65 and older is projected to rise from 10% in 2022 to 16% in 2050, reaching 94 million individuals, constituting 23% of the total population by 2050. Thus, the expanding geriatric population is a key factor propelling the overactive bladder treatment market's growth.

The prevalence of bladder cancer is another significant driver for the growth of the overactive bladder treatment market. Bladder cancer, characterized by abnormal cell growth in the bladder, often manifests with symptoms of overactive bladder. Treating these symptoms is crucial for improving the quality of life for individuals with bladder cancer. According to the American Society of Clinical Oncology's estimation in March 2023, around 82,290 adults in the United States are anticipated to be diagnosed with bladder cancer, with approximately 16,710 deaths expected in 2023. This underscores the correlation between bladder cancer and the prevalence of overactive bladder, contributing to the market's growth.

A notable trend in the overactive bladder treatment market is the approval of new products. Leading companies in the market are investing in the development of advanced products that incorporate the latest technologies to maintain their market positions. For example, in April 2023, Avation Medical Inc., a US-based company specializing in advanced neuromodulation and digital health, received FDA clearance for The Vivally System. This non-invasive bladder control therapy device, along with its accompanying mobile application, is designed to treat individuals suffering from urge urinary incontinence and urine urgency linked to overactive bladder syndrome. The system combines an ankle-worn garment with an intelligent controller, delivering personalized neuromodulation energy to the tibial nerve.

Innovation in treatments is a key focus for major companies in the overactive bladder treatment market. One such innovation involves the development of adrenergic receptor agonists, which mimic the effects of natural neurotransmitters to bind to adrenergic receptors. For instance, in April 2021, Urovant Sciences Ltd., a US-based clinical-stage biopharmaceutical company, introduced GEMTESA (vibegron) 75 mg tablets. This oral, once-daily medication is designed to address overactive bladder symptoms in adults, gaining approval from the U.S. Food and Drug Administration (FDA) as the first in its class for treating overactive bladder. Common side effects include dry mouth, headache, and constipation.

In March 2021, Sumitovant Biopharma, a US-based biopharmaceutical company, acquired Urovant Sciences Ltd. for an undisclosed amount. This strategic move is expected to provide long-term capital for business objectives and emphasize Sumitovant's commitment to developing and commercializing innovative therapies for urologic conditions, including overactive bladder treatments.

Major companies operating in the overactive bladder treatment market report are AbbVie Inc., Astellas Pharma Inc., Laborie Medical Technologies Corporation, Endo International plc, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson Services Inc., Medtronic plc, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Limited, Cogentix Medical Inc., Dr. Reddy's Laboratories Ltd., Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Limited, Merck & Co. Inc., Macleods Pharmaceuticals Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Mesoblast Limited, Novartis International AG, Novo Nordisk A/S, Daiichi Sankyo Company ltd., Boston Scientific Corporation, Grunenthal GmbH, Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc

North America was the largest region in the overactive bladder treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the overactive bladder treatment market report during the forecast period. The regions covered in the overactive bladder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the overactive bladder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The overactive bladder treatment market consists of revenues earned by entities by providing treatments such as behavioral therapies, nerve stimulation, and percutaneous tibial nerve stimulation (PTNS). The market value includes the value of related goods sold by the service provider or included within the service offering. The overactive bladder treatment market also includes sales of medications used in providing overactive bladder treatment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Overactive Bladder Treatment Market Characteristics

3. Overactive Bladder Treatment Market Trends And Strategies

4. Overactive Bladder Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Overactive Bladder Treatment Market Size and Growth

• 5.1. Global Overactive Bladder Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Overactive Bladder Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Overactive Bladder Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Overactive Bladder Treatment Market Segmentation

• 6.1. Global Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Idiopathic Bladder Overactivity
• Neurogenic Bladder Overactivity
• 6.2. Global Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Anticholinergics
• Mirabegron
• Neurostimulation
• Intravesical Instillation
• Other Therapies
• 6.3. Global Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Drug Stores And Retail Pharmacies
• Online Providers

7. Overactive Bladder Treatment Market Regional And Country Analysis

• 7.1. Global Overactive Bladder Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Overactive Bladder Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Overactive Bladder Treatment Market

• 8.1. Asia-Pacific Overactive Bladder Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Overactive Bladder Treatment Market

• 9.1. China Overactive Bladder Treatment Market Overview
• 9.2. China Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Overactive Bladder Treatment Market

• 10.1. India Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Overactive Bladder Treatment Market

• 11.1. Japan Overactive Bladder Treatment Market Overview
• 11.2. Japan Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Overactive Bladder Treatment Market

• 12.1. Australia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Overactive Bladder Treatment Market

• 13.1. Indonesia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Overactive Bladder Treatment Market

• 14.1. South Korea Overactive Bladder Treatment Market Overview
• 14.2. South Korea Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Overactive Bladder Treatment Market

• 15.1. Western Europe Overactive Bladder Treatment Market Overview
• 15.2. Western Europe Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Overactive Bladder Treatment Market

• 16.1. UK Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Overactive Bladder Treatment Market

• 17.1. Germany Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Overactive Bladder Treatment Market

• 18.1. France Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Overactive Bladder Treatment Market

• 19.1. Italy Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Overactive Bladder Treatment Market

• 20.1. Spain Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Overactive Bladder Treatment Market

• 21.1. Eastern Europe Overactive Bladder Treatment Market Overview
• 21.2. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Overactive Bladder Treatment Market

• 22.1. Russia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Overactive Bladder Treatment Market

• 23.1. North America Overactive Bladder Treatment Market Overview
• 23.2. North America Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Overactive Bladder Treatment Market

• 24.1. USA Overactive Bladder Treatment Market Overview
• 24.2. USA Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Overactive Bladder Treatment Market

• 25.1. Canada Overactive Bladder Treatment Market Overview
• 25.2. Canada Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Overactive Bladder Treatment Market

• 26.1. South America Overactive Bladder Treatment Market Overview
• 26.2. South America Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Overactive Bladder Treatment Market

• 27.1. Brazil Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Overactive Bladder Treatment Market

• 28.1. Middle East Overactive Bladder Treatment Market Overview
• 28.2. Middle East Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Overactive Bladder Treatment Market

• 29.1. Africa Overactive Bladder Treatment Market Overview
• 29.2. Africa Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Overactive Bladder Treatment Market Competitive Landscape And Company Profiles

• 30.1. Overactive Bladder Treatment Market Competitive Landscape
• 30.2. Overactive Bladder Treatment Market Company Profiles
  • 30.2.1. AbbVie Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Astellas Pharma Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Laborie Medical Technologies Corporation
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Endo International plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Hisamitsu Pharmaceutical Co. Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Overactive Bladder Treatment Market Competitive Benchmarking

32. Global Overactive Bladder Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Overactive Bladder Treatment Market

34. Overactive Bladder Treatment Market Future Outlook and Potential Analysis

• 34.1 Overactive Bladder Treatment Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Overactive Bladder Treatment Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Overactive Bladder Treatment Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer